Aethlon Medical INC Form 4 insider transactions

Director Chetan Shah reported a forfeiture of 2,182 shares of common stock in Aethelon Medical Inc. to cover tax withholdings related to the conversion of restricted stock units.

Director Nicolas Gikakis reported a transaction involving the forfeiture of 2,182 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Aethelon Medical Inc. director Edward G. Broenniman reported a transaction involving the forfeiture of 1,091 shares of common stock to cover tax withholdings.

Director Angela Rossetti was granted 21,815 restricted stock units in Aethlon Medical, vesting quarterly through March 2027.

Director Chetan Shah was granted 21,815 restricted stock units in Aethlon Medical, vesting quarterly through March 2027.

Director Edward G. Broenniman acquired 21,815 shares of Aethlon Medical common stock via restricted stock units.

Director Nicolas Gikakis acquired 21,815 restricted stock units in Aethlon Medical Inc. as part of a compensation grant.

Aethlon Medical Director Chetan Shah reported a forfeiture of 178 common shares to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Nicolas Gikakis forfeited 178 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Edward G. Broenniman forfeited 89 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Chetan Shah forfeited 179 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Nicolas Gikakis forfeited 179 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Edward G. Broenniman forfeited 89 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Nicolas Gikakis forfeited 1,786 shares of common stock to cover tax withholdings related to vested restricted stock units.

Aethlon Medical Director Edward G. Broenniman forfeited 893 common shares to cover tax withholdings related to restricted stock unit conversion.

Aethlon Medical Director Chetan Shah forfeited 1,786 common shares to cover tax withholdings upon the conversion of restricted stock units.

Aethlon Medical Director Edward G. Broenniman forfeited 893 shares of common stock to cover tax withholdings upon the conversion of 4,465 vested restricted stock units.

Aethlon Medical Inc. Director Nicolas Gikakis forfeited 1,786 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Aethlon Medical Inc. Director Chetan Shah forfeited 1,786 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Director Nicolas Gikakis reports acquisition of Aethlon Medical shares through a restricted stock unit (RSU) grant.

Director Angela Rossetti acquired 142,857 shares of Aethlon Medical Inc. through restricted stock units (RSUs) at a price of $0.35 on April 23, 2025.

Director Edward G. Broenniman acquired 142,857 shares of Aethlon Medical Inc. at $0.35 per share through the grant of Restricted Stock Units (RSUs).

Director Chetan Shah acquired 142,857 shares of Aethlon Medical Inc. through restricted stock units (RSUs) at a price of $0.358 per share.

Director Edward G. Broenniman forfeited 1,645 shares of Aethlon Medical common stock to cover tax obligations upon the conversion of restricted stock units.

Chetan Shah, a director at Aethlon Medical, forfeited 3,289 shares of common stock to cover tax obligations upon the conversion of restricted stock units.

Director Nicolas Gikakis forfeited 3,289 shares of Aethlon Medical common stock to cover tax obligations upon the conversion of restricted stock units.

Aethlon Medical director Edward G. Broenniman forfeited 1,645 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Aethlon Medical director Chetan Shah forfeited 3,289 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Nicolas Gikakis, a director at Aethlon Medical, forfeited 3,289 shares of common stock to cover tax obligations upon the conversion of restricted stock units.

Director Nicolas Gikakis forfeited 3,289 shares of Aethlon Medical common stock to cover tax obligations upon conversion of restricted stock units.